Virus influenza gripe, reasortante, vivo atenuado, cepa similar a a/ missouri/11/2025 pdm09,, Virus influenza gripe, reasortante, vivo atenuado cepa similar a a/darwin/1454/2025, Virus influenza gripe reasortante,vivo, atenuado, cepa similar a b/ tokyo/eis13-175/2025,

Fluenz Suspension Para Pulverizacion Nasal

7,0 ± 0,5 FFU + 7,0 ± 0,5 FFU + 7,0 ± 0,5 FFU suspensión para pulverización nasalSpainMarketedAuthorised 11 Jun 2024

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

FluenzEuropean UnionAuthorised

Packs

Pack	Code	Status
FLUENZ SUSPENSION PARA PULVERIZACION NASAL, 1 aplicador nasal	764648
FLUENZ SUSPENSION PARA PULVERIZACION NASAL, 10 aplicadores nasales	764649

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Virus influenza gripe, reasortante, vivo atenuado, cepa similar a a/ missouri/11/2025 pdm09,, Virus influenza gripe, reasortante, vivo atenuado cepa similar a a/darwin/1454/2025, Virus influenza gripe reasortante,vivo, atenuado, cepa similar a b/ tokyo/eis13-175/2025,

Fluenz Suspension Para Pulverizacion Nasal

7,0 ± 0,5 FFU + 7,0 ± 0,5 FFU + 7,0 ± 0,5 FFU suspensión para pulverización nasalSpainMarketedAuthorised 11 Jun 2024

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

FluenzEuropean UnionAuthorised

Packs

Pack	Code	Status
FLUENZ SUSPENSION PARA PULVERIZACION NASAL, 1 aplicador nasal	764648
FLUENZ SUSPENSION PARA PULVERIZACION NASAL, 10 aplicadores nasales	764649

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Virus influenza gripe, reasortante, vivo atenuado, cepa similar a a/ missouri/11/2025 pdm09,, Virus influenza gripe, reasortante, vivo atenuado cepa similar a a/darwin/1454/2025, Virus influenza gripe reasortante,vivo, atenuado, cepa similar a b/ tokyo/eis13-175/2025,
Strength: 7,0 ± 0,5 FFU + 7,0 ± 0,5 FFU + 7,0 ± 0,5 FFU
Dosage form: suspensión para pulverización nasal
Route: vía nasal
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 11 Jun 2024
Registration: 1241816001
Marketing authorisation holder: Astrazeneca Ab
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/24/1816